Literature DB >> 22376138

Characterisation of aflatoxin and deoxynivalenol exposure among pregnant Egyptian women.

S Piekkola1, P C Turner, M Abdel-Hamid, S Ezzat, M El-Daly, S El-Kafrawy, E Savchenko, T Poussa, J C S Woo, H Mykkänen, H El-Nezami.   

Abstract

Mycotoxins such as the aflatoxins and deoxynivalenol (DON) are frequent contaminants of food. Aflatoxin B1 (AFB1) and DON affect the immune system and restrict growth; additionally AFB1 is carcinogenic. To date there are limited descriptive biomarker data concerning maternal exposures during pregnancy, and none on co-exposures to these mycotoxins. This survey was a cross-sectional assessment providing descriptive data on the concentrations of serum aflatoxin-albumin (AF-alb), urinary aflatoxin M1 (AFM1), and urinary DON for 98 pregnant women from Egypt, in relation to diet and socioeconomic status, during the third trimester. AF-alb was detected in 34 of 98 (35%) samples, geometric mean (GM) of positives = 4.9 pg AF-lys mg(-1) albumin (95% confidence interval (CI) = 4.1-5.8 pg mg(-1)), and AFM1 in 44 of 93 (48%) samples, GM of positives = 19.7 pg mg(-1) creatinine (95%CI = 14.8-26.3 pg mg(-1)). AF-alb and AFM1 levels were positively correlated (R = 0.276, p = 0.007). DON was detected in 63 of 93 (68%), GM of positives = 2.8 ng mg(-1) (95%CI = 2.1-3.6 ng mg(-1)). Aflatoxin and DON biomarkers were observed in 41% of the subjects concurrently. The frequency and level of these biomarkers in Egyptian women were modest compared with known high-risk countries. However, this study represents the first biomarker survey to report on the occurrence of DON biomarkers in an African population, in addition to the co-occurrence of these two potent mycotoxins. This combined exposure may be of particular concern during pregnancy given the potential of toxin transfer to the foetus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22376138     DOI: 10.1080/19440049.2012.658442

Source DB:  PubMed          Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess        ISSN: 1944-0057


  18 in total

1.  The human fecal microbiota metabolizes deoxynivalenol and deoxynivalenol-3-glucoside and may be responsible for urinary deepoxy-deoxynivalenol.

Authors:  Silvia W Gratz; Gary Duncan; Anthony J Richardson
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

Review 2.  Aflatoxin Exposure and Associated Human Health Effects, a Review of Epidemiological Studies.

Authors:  Yun Yun Gong; Sinead Watson; Michael N Routledge
Journal:  Food Saf (Tokyo)       Date:  2016-03-30

3.  Agricultural and nutritional education interventions for reducing aflatoxin exposure to improve infant and child growth in low- and middle-income countries.

Authors:  Marianne E Visser; Anel Schoonees; Chibundu N Ezekiel; Nicola P Randall; Celeste E Naude
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

4.  Determination of Deoxynivalenol in the Urine of Pregnant Women in the UK.

Authors:  Liz Wells; Laura Hardie; Courtney Williams; Kay White; Yunru Liu; Barbara De Santis; Francesca Debegnach; Georgio Moretti; Stephanie Greetham; Carlo Brera; Alan Rigby; Stephen Atkin; Thozhukat Sathyapalan
Journal:  Toxins (Basel)       Date:  2016-10-25       Impact factor: 4.546

Review 5.  Engaging One Health for Non-Communicable Diseases in Africa: Perspective for Mycotoxins.

Authors:  Carina Ladeira; Chiara Frazzoli; Orish Ebere Orisakwe
Journal:  Front Public Health       Date:  2017-10-16

Review 6.  LC-MS/MS-based multibiomarker approaches for the assessment of human exposure to mycotoxins.

Authors:  Benedikt Warth; Michael Sulyok; Rudolf Krska
Journal:  Anal Bioanal Chem       Date:  2013-06-18       Impact factor: 4.142

Review 7.  An overview on mycotoxin contamination of foods in Africa.

Authors:  Wageh Sobhy Darwish; Yoshinori Ikenaka; Shouta M M Nakayama; Mayumi Ishizuka
Journal:  J Vet Med Sci       Date:  2014-02-27       Impact factor: 1.267

8.  Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy.

Authors:  Chit Shing Jackson Woo; Hani El-Nezami
Journal:  Toxins (Basel)       Date:  2016-03-23       Impact factor: 4.546

9.  The Potential Role of Mycotoxins as a Contributor to Stunting in the SHINE Trial.

Authors:  Laura E Smith; Andrew J Prendergast; Paul C Turner; Mduduzi N N Mbuya; Kuda Mutasa; George Kembo; Rebecca J Stoltzfus
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

10.  Deoxynivalenol Exposure Assessment for Pregnant Women in Bangladesh.

Authors:  Nurshad Ali; Meinolf Blaszkewicz; Abdullah Al Nahid; Mustafizur Rahman; Gisela H Degen
Journal:  Toxins (Basel)       Date:  2015-09-24       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.